Model Number PD3030 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Seroma (2069); Hernia (2240)
|
Event Date 09/20/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
The information provided to date indicated that the xenograft remains implanted and not available for evaluation.Therefore, a comprehensive re-review will be conducted of the manufacturing records, sterilization run reports, environmental monitoring results, quality control / assurance reviews and release, and the complaint database for related complaints.Once results are available, a follow up will be submitted.
|
|
Event Description
|
Rti surgical, inc (rti) received a complaint notification on 10/06/2017 indicating that a patient underwent implantation of a fortiva porcine dermis on an unknown, as part of a hernia repair clinical study.On (b)(6) 2016, the patient developed a seroma (unknown location).To date, rti has not received additional information.
|
|
Manufacturer Narrative
|
Methods: the xenograft was not returned for evaluation.Therefore, a comprehensive re-review of manufacturing records, sterilization run reports, quality control/assurance reviews and release, and the complaint database for related complaints associated with the lot was conducted.Results: there were three departures noted during records re-review for lot mp151701.One departure was associated with damage to a graft's packaging.The graft associated with this departure was destroyed.The second departure was associated grafts entered in the system under the incorrect document type.However, the complaint graft was not involved or affected.The third departure was associated with exceeded airborne bioburden.Additional testing was performed and was acceptable.Bioburden testing on all the grafts was within specification.The investigation concluded that these departures did not have a negative impact on the quality of the complaint graft.Xenografts manufactured from lot mp151701, underwent a validated sterilization methodology: tutoplast, which includes terminal sterilization by gamma irradiation after packaging.Serial id (b)(4) met all rti/tmi specifications and release criteria prior to distribution.To date, rti/tmi has manufactured a total of (b)(4) xenograft and distributed a total of (b)(4) xenograft from the lot without related complaints.Based on our records re-review and the complaint information provided to date, it is more plausible that the patient's operative complications were associated with an event of source extrinsic to the xenograft implants.
|
|
Search Alerts/Recalls
|
|